Connect to Pharmapack

The pharmaceutical packaging market has constantly been growing and changing in the past few years. The increasing need for sustainability in pharma packaging, more sophisticated and trackable packaging to advance safety and the rising demand for autoinjectors are drivers of innovation and differentiation....

• Market needs for a device to deliver high drug loads to lungs. • Introduction to the Orbital device – features and benefits. • Comparative performance of Orbital to other DPI devices. • Different types of molecules and formulations made using different particle engineering technologies, inc...

The new EZ-Fill Smart™ Platform for Vials offers a powerful route improving pharmaceutical manufacturing quality standard while reducing the Total Cost of Ownership (TCO).

The pharmaceutical supply chain is complex, and pharmaceutical companies must address the most common challenges to efficiently get patients their needed medications. Despite present challenges, the supply chain is prepared to accommodate drug delivery technology in a new era of patient healthcare. This se...

Biosimilar drugs offer cost-effective ground-breaking therapies to ever-expanding markets across the World. Some of these drugs are intended for self-injection using autoinjectors for enhanced usability and patient safety. Developing devices for biosimilars requires a greater focus on the cost of goods and...

We at Körber believe the pharmaceutical industry will ultimately dispense of plastic packaging within a few years. Our Rondo Solutions are pioneering when it comes to sustainability. Today pharmaceutical packaging expects to be innovative, compact, safe, and environmentally friendly. That’s because opin...

Advances in auto-injector design now provide the option to use both 1ml and 2.25mL syringes plus employ technology to adapt to varying fill volumes and viscosities all whilst maintaining the same device form. This provides a solution for the formulation changes that take place during drug development, clin...

As the number of patients managing chronic diseases continues to increase, self-injection solutions play an important role in enabling the shift towards home care. Identification of potential use errors is a critical task during device development to support patient acceptance and usability. The design of ...

Country regulations are swiftly moving to enforce the reporting of the carbon footprint from medicinal products. A large proportion of emissions are generated from packaging and drug delivery devices, two areas that have been identified as strategic focus areas in which clear action can be taken. Healthcar...

This session will showcase how synergies between a small molecule formulation team, human factors, and packaging have led to better patient-centric solutions. In addition, it will touch upon Some of the principles to consider for patient-centric development and well as well as highlight some of Roche's...

This session will give insights on the trends our sector is facing: decarbonization and circular economy. It will also provide an overview on the work done at industry level. And finally, you will be able to learn more on what Saint-Gobain Life Sciences is willing to offer to supply single-use technologies...

Advances in auto-injector design now provide the option to use both 1ml and 2.25mL syringes plus employ technology to adapt to varying fill volumes and viscosities all whilst maintaining the same device form. This provides a solution for the formulation changes that take place during drug development, clin...

In 2022, the final recommendations of the Product Quality Research Institute were published for Parenteral Drug Products. Apart from the wealth of information and considerations on design of extractable & leachable studies for parenteral drug products in general, it also contains valuable information on sp...

Connecting medication and medical devices to the internet can enhance product protection, improve patient safety and outcomes, and optimize processes along complex supply chains. NFC-RFID technologies are increasingly used to provide connectivity benefits more securely and efficiently, ensuring that pharma...

Human Factors Engineering (HFE) process participates in the product development for a safe and effective use by the end-user population. HFE data are under agencies' scrutiny as part of the design control of a drug - device combination product. Timely planning can be challenging during combination product ...

Ability to achieve successful injection of drug or biologic depends on many factors including but not limited to needle diameter, drug viscosity, spring force, lubrication, plunger geometry and material properties. One additional challenge to be considered during verification of the drug delivery system i...

Transitioning drugs from IV to subcutaneous (SC) delivery brings new requirements and impacts program considerations for combination product development. In this session, we identify trade-offs that pharma weighs to de-risk combination product development programs involving large volume subcutaneous (LVSC...

The presentation will look in some detail how aging / stability studies are established and address the following • What is aging / stability? • What is purpose of aging / stability testing? • What about relative humidity? • What risks are involved? • How long is the shelf life of your prod...

Besides the large multinational players, the pharmaceutical packaging market is still very fragmented. Packaging companies face increasing size pressure from customers and suppliers. Regulatory and R&D requirements are increasing with a heavily rising cost base, are strategic alliances the right answer to ...

The pharmaceutical industry has recognized the urgency in reducing their CO2 footprint and the need to address the climate change as well as the global waste crisis through circularity. Solutions towards more circularity in the industry are therefore key and the traditional take-make-dispose linear product...

This session will touch upon consumer behaviours of smart devices, their adoption and usage while measuring consumer preferences and habits around digital products and services. The session will pose questions about which devices people have access to and how often they use them while comparing the tr...

Implementing sustainability in pharmaceutical packaging needs a two-way methodology: on the one hand, a scientific, data-driven approach to support today’s industrial solutions; on the other hand, a ground-breaking , never-stopping innovation research to anticipate future evolutions. With this Learning...

The climate crisis is, without a doubt, one of the biggest challenges to the existence of humankind. The Pharma Sector sure has quite some potential in ensuring its footprint becomes much less: The total global emissions of the Pharma Sector amounted to 52 megatonnes of CO2e (2015) – more than the automoti...

The complexity and risks found within the global pharma supply chain cannot be understated and key stakeholders from customers to regulators and investors are increasingly expecting the industry to both manage ESG risks and embed sustainability throughout the value chain. This can only be achieved through ...

New therapeutic treatments or prophylactic vaccines rely on more complicated drug formulations, often based on biologics. These drugs are highly sensitive and might require low temperature storage to keep them stable over shelf life. These extreme cold supply chain processes, something up to -80°C, provide...

Patients are in need. Yet, patient involvement cannot be overcome by providing a solution that effectively and safely meets a need and is well tolerated. Patients, more concerned than ever with their health, are demanding more of such solutions. In this talk, we'll discover that if your solution meets t...

OXYCAPT is a multilayer plastic vial that consists of three layers, COP/New Polyester/COP. The product has achieved excellent oxygen & ultraviolet (UV) light barrier, very low extractables, high pH stability, low protein adsorption, high transparency, high break resistance, lightweight, etc. For example, t...

Lyophilization (freeze drying) is a proven process for increasing the shelf life of vaccines, biologics and other injectables. But delivering these products requires several use steps that make them challenging to administer, particularly by patients and caregivers in non-clinical settings. To address thes...

This session will aim to bring together experts in the industry to discuss the trends around driving self-administration drug delivery systems and expected practices for developing an injectable combination product. Join us in this panel to discuss about: When is it appropriate to convert conventional i...

Whether it is for new drug development or Vial-to-Prefilled Life Cycle Management projects, choosing the right primary packaging components is essential and will condition the success of the formulation, as well as the manufacturing and commercialization. As PFS components come in direct contact with the d...

Since the introduction of the new MDR, usability engineering has been put into the focus of lifecycle development. Especially for combination products, submissions to notified bodies require additional usability considerations and efforts. This session will introduce attendees to essential aspects requi...

Regulations and changing customer expectations are redefining the need for pharmaceutical providers to take back used devices and packaging. These items are often made of materials not accepted in household recycling schemes. These changes drive the need to understand design for recyclability, collections ...

The presentation will focus on pressing over the pain points of Pharma Manufacturing, where we present the ECOSYSTEM of Körber Pharma as a great solution. I plan to address the burning questions - What is an Ecosystem and why is it so important in Pharma Manufacturing? The specific details on exploring ...

Our healthcare industry is evolving. The move from IV to SC injection is being driven by lifecycle management, biosimilar adoption, and the hospital to home trend. Molecules are getting more complex, and patients drive the preference for self-administration resulting in the need for more complex combinatio...

Packaging is an integral part of the design for pharmaceutical products and medical devices. Not only does one need to take into account the look, feel, and protective qualities of the packaging but design must be considered when determining the sterilization technology. Determining the sterilization techn...

Rubber compound FM30 is a well know compound offered by all big syringe manufacturers these days. It is a low extractable compound with a high gas permeability and is suitable for producing both a needle shield and a tip cap which are sterilized by ethylene oxide. There is a clear trend to move from the ...

This session will highlight how robotic aseptic fill/finish equipment offers the flexibility to adjust to future growth and the speed to market necessary for today's changing industry: • How robotics offers new answers to today's challenges • Leveraging semi-automated to completely automated and ...

In recent years there are several market trends which are influencing the design of drug delivery devices. The shift to patient care outside the traditional healthcare setting, accelerated by the pandemic, has led to an increase in patient self- treatment. This has also resulted in the need for connected d...

For the past 20 years in healthcare, Polypropylene (PP) has been the most utilized plastic across a range of applications, from high-risk applications such as IV parenteral packaging to medical devices and diagnostics. PP offers alternatives to glass, metal and other plastics, such as PS or PVC. The press...

Sub-optimal adherence and persistence to treatment continue to be significant challenges for both on-market drugs and investigational products in clinical development. This is especially true for self-administered medications for chronic disease patients, hence driving the need for improved treatment intak...

This panel discussion tackles: • Challenges around patient digital adoption • The need for user engagement to create meaningful solutions • The use of digital products to improve patient experience in clinical trials • Challenges of designing information – the use of eIFUs to create opportuni...